Abstract

Poor aqueous solubility of drug substances is associated with poor bioavailability and thus hampers the effective use of many potent active pharmaceutical ingredients. Various strategies to overcome poor solubility are available, whereby drug nanocrystals represent one of the most powerful formulation strategies to enhance the kinetic solubility and dissolution rate of poorly soluble drugs. Nanocrystals are simply obtained by milling large-sized drug powders to sizes < 1 µm. The so obtained nanocrystals possess an increased dissolution rate and kinetic solubility when compared with larger-sized bulk material. The aim of this study was to produce differently sized hesperetin nanocrystals and to investigate the influence of nanocrystal size on the bioefficacy of the natural antioxidant hesperetin in two cell culture models for the prevention and treatment of Alzheimer’s disease. Results showed that the testing of poorly soluble compounds is challenging and requires incredibly careful characterization. Reasons for this are possible changes of the formulations in cell culture media which can occur due to various reasons. If the changes are not considered, results obtained can be misleading and even lead to a false interpretation of the results obtained. Besides, results demonstrate the increase in dissolution rate with decreasing particle size that is especially pronounced with particle sizes < 200 nm. Data also provide clear evidence that smaller nanocrystals with higher kinetic solubility possess higher antioxidant capacity. This results in lower amounts of free radicals in the cell culture models, suggesting that hesperetin nanocrystals, that improve the poor aqueous solubility of hesperetin, are promising for the prevention and treatment of Alzheimer’s disease.Graphical abstract

Highlights

  • Hesperetin is a secondary plant metabolite that is found in various plants

  • If potent antioxidants are added to the cells, the vitality of the cells increases which results in an increase in adenosine triphosphate (ATP) levels

  • Our study showed that smaller-sized particles (< 200 nm) with a more hydrophobic surface could be obtained by bead milling (BM), whereas larger-sized nanocrystals (> 300 nm) with a more hydrophilic surface were obtained by high-pressure homogenization (HPH)

Read more

Summary

Introduction

Hesperetin is a secondary plant metabolite that is found in various plants. It is well-known for its antioxidant properties and possesses a great potential to be used as therapeutic active to treat or prevent oxidative stress-related diseases. The major hurdle that needs to be overcome is its poor aqueous solubility, which results in poor bioavailability [3, 4]. The most well-known formulation principle to increase the dissolution rate and the solubility of poorly soluble APIs is the production of drug nanocrystals [6,7,8,9,10,11]. Nanocrystals are composed of 100% API and possess sizes below 1 μm.

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call